臨床試驗支援服務市場規模、佔有率及成長分析（按服務、階段、研究設計、適應症、發起方和地區）－2025 年至 2032 年產業預測

臨床試驗支援服務市場規模預計在 2023 年達到 230 億美元，從 2024 年的 248.4 億美元成長到 2032 年的 459.8 億美元，預測期內（2025-2032 年）的複合年成長率為 8.0%。

臨床試驗產業經歷了重大變革，尤其是自疫情爆發以來，重點關注臨床試驗、檢測設計和支援服務。保護和儲存研究藥物、確保臨床實驗地點的安全、計算藥物劑量和管理套件等基本業務在這一領域發揮關鍵作用。許多被推遲的臨床試驗的恢復，特別是在2021年新冠疫苗研發之後，也凸顯了新興市場迫切需要創新藥物來應對日益增多的慢性病、感染疾病和熱帶病。此外，向虛擬臨床試驗的轉變已成為臨床試驗支援服務收益成長的主要驅動力，研究公司擴大採用虛擬技術來提高其臨床研究方法的效率。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 二次資料和一次資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態與展望

• 市場概覽
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024年）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 定價分析

臨床試驗支援服務市場規模（按服務類型和複合年成長率）（2025-2032）

• 市場概覽
• 管理人員
• 臨床試驗現場管理
  • 病患招募及登記服務
  • 病患招募管理
  • 患者保留
• 資料管理
• 機構審查委員會

臨床試驗支援服務市場規模（分階段）及複合年成長率（2025-2032）

• 市場概覽
• 第一階段
• 第二階段
• 第三階段
• 第四階段

臨床試驗支援服務市場規模（依研究設計和複合年成長率） (2025-2032)

• 市場概覽
• 擴展訪問
• 介入
• 觀察性

臨床試驗支援服務市場規模（按適應症和複合年成長率）（2025-2032）

• 市場概覽
• 自體免疫或炎症
• 心血管
• 糖尿病
• 腫瘤學

臨床試驗支援服務市場規模（按贊助商和複合年成長率） (2025-2032)

• 市場概覽
• 醫療設備
• 製藥和生物製藥

臨床試驗支援服務市場規模（按地區）及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024年）
• 主要企業簡介
  • 公司詳情
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• Laboratory Corporation of America Holdings（LabCorp）（USA）
• Charles River Laboratories International, Inc.（USA）
• Syneos Health, Inc.（USA）
• Parexel International Corporation（USA）
• ICON plc（Ireland）
• Wuxi AppTec Co., Ltd.（China）
• Eurofins Scientific（Luxembourg）
• ACM Global Laboratories（USA）
• Clinipace Worldwide（USA）
• Worldwide Clinical Trials（USA）
• Premier Research（USA）
• PSI CRO AG（Switzerland）
• Novotech（Australia）
• Velocity Clinical Research（USA）
• Fortrea（USA）
• CTI Clinical Trial and Consulting Services（USA）

結論和建議

Clinical Trials Support Services Market size was valued at USD 23.0 billion in 2023 and is poised to grow from USD 24.84 billion in 2024 to USD 45.98 billion by 2032, growing at a CAGR of 8.0% during the forecast period (2025-2032).

The clinical trials industry has witnessed significant evolution, particularly post-pandemic, with an emphasis on clinical testing, assay design, and support services. Essential operations such as securing and storing research medications, safeguarding trial sites, calculating drug dosages, and managing kits play a vital role in this domain. The resurgence of numerous postponed trials, particularly after the development of COVID-19 vaccines in 2021, has also highlighted the urgent need for innovative pharmaceuticals to address rising chronic, infectious, and tropical diseases in emerging markets. Additionally, the shift towards virtual clinical trials has emerged as a key driver of revenue growth in clinical trial support services, as research firms increasingly adopt virtual technologies to enhance the efficiency of their clinical research processes.

Top-down and bottom-up approaches were used to estimate and validate the size of the Clinical Trials Support Services market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Clinical Trials Support Services Market Segments Analysis

Global Clinical Trials Support Services Market is segmented by Service, Phase, Study Design, Indication, Sponsor and region. Based on Service, the market is segmented into Administrative Staff, Clinical Trial Site Management, Data Management and Institutional Review Boards. Based on Phase, the market is segmented into Phase I, Phase II, Phase III and Phase IV. Based on Study Design, the market is segmented into Expanded Access, Interventional and Observational. Based on Indication, the market is segmented into Autoimmune or Inflammation, Cardiovascular, Diabetes and Oncology. Based on Sponsor, the market is segmented into Medical Devices and Pharmaceutical & Biopharmaceutical. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Clinical Trials Support Services Market

The growth of the Clinical Trials Support Services market is primarily driven by several key factors, including the increasing prevalence of infectious and chronic diseases, which necessitates extensive research efforts. Additionally, pharmaceutical companies are investing significantly in research and development, further fueling market expansion. The rise of contract research organizations (CROs) is also contributing to this trend, as they offer specialized expertise and resources for conducting clinical trials. Furthermore, the escalating demand for clinical trials in emerging markets is creating new opportunities, ultimately driving the overall growth and evolution of the Clinical Trials Support Services landscape.

Restraints in the Clinical Trials Support Services Market

The growth of the Clinical Trials Support Services market is hindered by insufficient medical infrastructure and advanced technological equipment. Moreover, strict regulations surrounding patient recruitment and the absence of robust management frameworks for the trials pose significant challenges to the market's overall development. However, there remains a promising opportunity for growth driven by the globalization of clinical trials and continuous advancements in technology resulting from ongoing research and development efforts. Addressing these constraints could pave the way for a more dynamic market environment, fostering innovation and improving the efficiency of clinical trial processes.

Market Trends of the Clinical Trials Support Services Market

The Clinical Trials Support Services market is poised for significant growth due to several key trends. The increasing demand for clinical trials in emerging nations, propelled by improved regulatory frameworks and healthcare infrastructure, is driving expansion. Additionally, rising research and development (R&D) investments from pharmaceutical companies, largely fueled by patent expirations, are escalating the need for efficient trial execution. The proliferation of contract research organizations (CROs) further enhances this trend, as they offer specialized services that streamline the trial process and reduce costs. Collectively, these factors indicate a robust and rapidly expanding global market for clinical trials support services.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Clinical Trials Support Services Market Size by Service & CAGR (2025-2032)

• Market Overview
• Administrative Staff
• Clinical Trial Site Management
  • Patient Recruitment & Registry Services
  • Patient Recruitment Management
  • Patient Retention
• Data Management
• Institutional Review Boards

Global Clinical Trials Support Services Market Size by Phase & CAGR (2025-2032)

• Market Overview
• Phase I
• Phase II
• Phase III
• Phase IV

Global Clinical Trials Support Services Market Size by Study Design & CAGR (2025-2032)

• Market Overview
• Expanded Access
• Interventional
• Observational

Global Clinical Trials Support Services Market Size by Indication & CAGR (2025-2032)

• Market Overview
• Autoimmune or Inflammation
• Cardiovascular
• Diabetes
• Oncology

Global Clinical Trials Support Services Market Size by Sponsor & CAGR (2025-2032)

• Market Overview
• Medical Devices
• Pharmaceutical & Biopharmaceutical

Global Clinical Trials Support Services Market Size & CAGR (2025-2032)

• North America (Service, Phase, Study Design, Indication, Sponsor)
  • US
  • Canada
• Europe (Service, Phase, Study Design, Indication, Sponsor)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Service, Phase, Study Design, Indication, Sponsor)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Service, Phase, Study Design, Indication, Sponsor)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Service, Phase, Study Design, Indication, Sponsor)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Laboratory Corporation of America Holdings (LabCorp) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Charles River Laboratories International, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Syneos Health, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Parexel International Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ICON plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Wuxi AppTec Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific (Luxembourg)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ACM Global Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Clinipace Worldwide (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Worldwide Clinical Trials (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Premier Research (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PSI CRO AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novotech (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Velocity Clinical Research (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fortrea (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CTI Clinical Trial and Consulting Services (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations